Current Evolutions in Axillary Management

[摘要] Rubio: Actually, we can omit SLN in those patients >70y/o in whom the results of the SLN would not changetreatment, as far as the axilla is clinically negative (US).Gentilini: At the moment, SLNS is still the standard ofcare for axillary staging in early breast cancer. Data fromrandomized trial will help refining the indications but forthe time being SLNB might be omitted in elderly or frailpatients in whom the information from SLNB is not affecting the treatment plan. In those patients, we suggestto perform axillary ultrasound as a simple, not expensive,and reproducible technique to rule out lymph node involvement which might be missed by clinical evaluationalone.

[学科分类] 泌尿医学